Trial
NCT00449111
An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Organon and Co
Collaborators
—
Condition
Hypertension
Intervention
MK0954, losartan potassium / Duration of Treatment - 12 weeks
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-15